Key result
Newer rotary LVAS improve survival and reduce adverse events versus first-generation pulsatile devices.
Population
Advanced heart failure patients
Design
Review
Authors
Loading...
May inform rotary LVAS selection in advanced HF; leaves open need for randomized confirmation.
This review outlines the technological evolution of implantable LVAS for advanced heart failure, emphasizing the transition to rotary blood pumps to mitigate complications associated with earlier pulsatile devices.
Chisato Nojiri (2009) conducted a review in Advanced heart failure. Implantable Left Ventricular Assist Systems (LVAS) was evaluated. Newer generation rotary pump left ventricular assist systems demonstrate better survival outcomes, mechanical reliability, and decreased adverse event rates compared to first-generation pulsatile devices.
Synapse has enriched 4 closely related papers on similar clinical questions. Consider them for comparative context: